CLINICAL_TRIALS
trial_result
· 2014-02-21
Clinical Trial Update: STI571 in Treating Patients With Recurrent Leukemia [Phase 1]
Summary
This document reports the completion of a Phase 1 clinical trial of STI571 (imatinib) in patients with recurrent leukemia. The trial was sponsored by the Childr…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Children's Oncology Group | Conditions: Leukemia | Phase 1 | Status: COMPLETED